Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vandyck

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
Nature Communications|June 25, 2026
Three immunoregulatory signatures define non-productive HIV infection in stem cell memory CD4<sup>+</sup> T cellsGiacomo M Butta, Bremy Alburquerque, Charlotte Kearns, et al.
The Journal of Organic Chemistry|December 8, 2010
Practical synthesis of (2'R)-2'-deoxy-2'-C-methyluridine by highly diastereoselective homogeneous hydrogenationSébastien Lemaire, Ioannis Houpis, Rainer Wechselberger, et al.
Plos One|December 11, 2020
Regulation of gene transcription by thyroid hormone receptor β agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH)Xuan G Luong, Sarah K Stevens, Andreas Jekle, et al.
Journal of Medicinal Chemistry|December 19, 2013
Nucleotide prodrugs of 2'-deoxy-2'-spirooxetane ribonucleosides as novel inhibitors of the HCV NS5B polymeraseTim H M Jonckers, Koen Vandyck, Leen Vandekerckhove, et al.
Antiviral Research|October 18, 2017
Characterization of a dengue NS4B inhibitor originating from an HCV small molecule libraryIlane Hernandez-Morales, Peggy Geluykens, Marleen Clynhens, et al.
Structure (London, England : 1993)|February 6, 2026
Structural basis for pan-coronavirus inhibition of 3CL proteaseEswar R Reddem, Farhad Forouhar, Cheng Liu, et al.
Biochemical and Biophysical Research Communications|April 4, 2021
ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster modelKoen Vandyck, Rana Abdelnabi, Kusum Gupta, et al.
Journal of Medicinal Chemistry|September 2, 2024
Discovery and Preclinical Profile of ALG-055009, a Potent and Selective Thyroid Hormone Receptor Beta (THR-β) Agonist for the Treatment of MASHKoen Vandyck, David C McGowan, Xuan G Luong, et al.
Journal of Virology|January 15, 2010
1a/1b subtype profiling of nonnucleoside polymerase inhibitors of hepatitis C virusOrigène Nyanguile, Benoit Devogelaere, Leen Vijgen, et al.
American Journal of Obstetrics & Gynecology MFM|January 4, 2025
Severe maternal morbidity contributed by obstetric hemorrhage: Maryland, 2020-2022Carrie Wolfson, Jessica Tsipe Angelson, Robert Atlas, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Nature Communications|June 25, 2026
Three immunoregulatory signatures define non-productive HIV infection in stem cell memory CD4<sup>+</sup> T cellsGiacomo M Butta, Bremy Alburquerque, Charlotte Kearns, et al.
The Journal of Organic Chemistry|December 8, 2010
Practical synthesis of (2'R)-2'-deoxy-2'-C-methyluridine by highly diastereoselective homogeneous hydrogenationSébastien Lemaire, Ioannis Houpis, Rainer Wechselberger, et al.
Plos One|December 11, 2020
Regulation of gene transcription by thyroid hormone receptor β agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH)Xuan G Luong, Sarah K Stevens, Andreas Jekle, et al.
Journal of Medicinal Chemistry|December 19, 2013
Nucleotide prodrugs of 2'-deoxy-2'-spirooxetane ribonucleosides as novel inhibitors of the HCV NS5B polymeraseTim H M Jonckers, Koen Vandyck, Leen Vandekerckhove, et al.
Antiviral Research|October 18, 2017
Characterization of a dengue NS4B inhibitor originating from an HCV small molecule libraryIlane Hernandez-Morales, Peggy Geluykens, Marleen Clynhens, et al.
Structure (London, England : 1993)|February 6, 2026
Structural basis for pan-coronavirus inhibition of 3CL proteaseEswar R Reddem, Farhad Forouhar, Cheng Liu, et al.
Biochemical and Biophysical Research Communications|April 4, 2021
ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster modelKoen Vandyck, Rana Abdelnabi, Kusum Gupta, et al.
Journal of Medicinal Chemistry|September 2, 2024
Discovery and Preclinical Profile of ALG-055009, a Potent and Selective Thyroid Hormone Receptor Beta (THR-β) Agonist for the Treatment of MASHKoen Vandyck, David C McGowan, Xuan G Luong, et al.
Journal of Virology|January 15, 2010
1a/1b subtype profiling of nonnucleoside polymerase inhibitors of hepatitis C virusOrigène Nyanguile, Benoit Devogelaere, Leen Vijgen, et al.
American Journal of Obstetrics & Gynecology MFM|January 4, 2025
Severe maternal morbidity contributed by obstetric hemorrhage: Maryland, 2020-2022Carrie Wolfson, Jessica Tsipe Angelson, Robert Atlas, et al.
Pageof 11